HUTCHMED (China) Ltd (HCM)
17.82
0.00 (0.00%)
USD |
NASDAQ |
Jun 26, 13:58
HUTCHMED Enterprise Value: 2.250B for June 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 25, 2024 | 2.250B |
| June 24, 2024 | 2.282B |
| June 21, 2024 | 2.267B |
| June 20, 2024 | 2.153B |
| June 18, 2024 | 2.247B |
| June 17, 2024 | 2.258B |
| June 14, 2024 | 2.299B |
| June 13, 2024 | 2.388B |
| June 12, 2024 | 2.265B |
| June 11, 2024 | 2.264B |
| June 10, 2024 | 2.293B |
| June 07, 2024 | 2.238B |
| June 06, 2024 | 2.354B |
| June 05, 2024 | 2.436B |
| June 04, 2024 | 2.429B |
| June 03, 2024 | 2.233B |
| May 31, 2024 | 2.369B |
| May 30, 2024 | 2.424B |
| May 29, 2024 | 2.392B |
| May 28, 2024 | 2.475B |
| May 24, 2024 | 2.404B |
| May 23, 2024 | 2.402B |
| May 22, 2024 | 2.566B |
| May 21, 2024 | 2.603B |
| May 20, 2024 | 2.636B |
| Date | Value |
|---|---|
| May 17, 2024 | 2.649B |
| May 16, 2024 | 2.784B |
| May 15, 2024 | 2.885B |
| May 14, 2024 | 2.859B |
| May 13, 2024 | 2.924B |
| May 10, 2024 | 2.919B |
| May 09, 2024 | 2.760B |
| May 08, 2024 | 2.530B |
| May 07, 2024 | 2.527B |
| May 06, 2024 | 2.590B |
| May 03, 2024 | 2.475B |
| May 02, 2024 | 2.545B |
| May 01, 2024 | 2.409B |
| April 30, 2024 | 2.366B |
| April 29, 2024 | 2.434B |
| April 26, 2024 | 2.306B |
| April 25, 2024 | 2.448B |
| April 24, 2024 | 2.349B |
| April 23, 2024 | 2.322B |
| April 22, 2024 | 2.098B |
| April 19, 2024 | 2.023B |
| April 18, 2024 | 1.999B |
| April 17, 2024 | 2.014B |
| April 16, 2024 | 2.054B |
| April 15, 2024 | 2.221B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
519.30M
Minimum
Oct 25 2022
6.526B
Maximum
Aug 09 2021
2.892B
Average
2.539B
Median
Sep 03 2019
Enterprise Value Benchmarks
| Global Pharmatech Inc | -- |
| Sino Biopharmaceutical Ltd | 7.123B |
| Pharmaron Beijing Co Ltd | -- |
| Regencell Bioscience Holdings Ltd | 48.41M |
| Prenetics Global Ltd | 12.17M |
Enterprise Value Related Metrics
| Earnings Yield | 3.09% |
| Operating Earnings Yield | 0.59% |
| Normalized Earnings Yield | 3.086 |